Acro Biomedical Co., Ltd.
ACBM· OTC
Acro Biomedical Co., Ltd.
- Close
- Apr 5, 2023
- Market cap
- $255.18M
- 60.04M shares
- Filings
- 91
Price
Apr 5, 2023 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $658,500 | reported | |
| FY 2021 | 2021-12-31 | $1,197,500 | reported | |
| FY 2020 | 2020-12-31 | $687,964 | reported | |
| FY 2019 | 2019-12-31 | $193,536 | reported | |
| FY 2018 | 2018-09-30 | $8,014,500 | reported | |
| FY 2017 | 2017-09-30 | $510,000 | reported |
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
